Open Orphan plc (LON:ORPH) has appointmented Yamin ‘Mo’ Khan as an Independent Non-Executive Director to the Board of Open Orphan.
With 25 years of global clinical research experience across clinical operations, project management, business development and executive management functions.
Mo is a business leader and customer-focused CRO executive having previously worked at Pharm-Olam International, a global CRO, from 2000-2019 across a variety of senior positions including Executive Vice President of Clinical Development and Global Director of Clinical Operations.
